[1] Refined preparation and use of anti-diglycine remnant (K-ε-GG) antibody enables routine quantification of 10,000s of ubiquitination sites in single proteomics experiments.
Udeshi ND, Svinkina T, Mertins P, Kuhn E, Mani DR, Qiao JW, Carr SA.
Mol Cell Proteomics. 2013 Mar;12(3):825-31. [
PMID: 23266961]
[2] Integrated proteomic analysis of post-translational modifications by serial enrichment.
Mertins P, Qiao JW, Patel J, Udeshi ND, Clauser KR, Mani DR, Burgess MW, Gillette MA, Jaffe JD, Carr SA.
Nat Methods. 2013 Jul;10(7):634-7. [
PMID: 23749302]
[3] Systematic and quantitative assessment of the ubiquitin-modified proteome.
Kim W, Bennett EJ, Huttlin EL, Guo A, Li J, Possemato A, Sowa ME, Rad R, Rush J, Comb MJ, Harper JW, Gygi SP.
Mol Cell. 2011 Oct 21;44(2):325-40. [
PMID: 21906983]
[4] Methods for quantification of in vivo changes in protein ubiquitination following proteasome and deubiquitinase inhibition.
Udeshi ND, Mani DR, Eisenhaure T, Mertins P, Jaffe JD, Clauser KR, Hacohen N, Carr SA.
Mol Cell Proteomics. 2012 May;11(5):148-59. [
PMID: 22505724]
[5] Lysine acetylation targets protein complexes and co-regulates major cellular functions.
Choudhary C, Kumar C, Gnad F, Nielsen ML, Rehman M, Walther TC, Olsen JV, Mann M.
Science. 2009 Aug 14;325(5942):834-40. [
PMID: 19608861]
[6] Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor.
Ledl A, Schmidt D, Müller S.
Oncogene. 2005 May 26;24(23):3810-8. [
PMID: 15806172]
[7] Interplay between lysine methylation and Cdk phosphorylation in growth control by the retinoblastoma protein.
Carr SM, Munro S, Kessler B, Oppermann U, La Thangue NB.
EMBO J. 2011 Jan 19;30(2):317-27. [
PMID: 21119616]
[8] A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles.
Wagner SA, Beli P, Weinert BT, Nielsen ML, Cox J, Mann M, Choudhary C.
Mol Cell Proteomics. 2011 Oct;10(10):M111.013284. [
PMID: 21890473]
[9] hCKSAAP_UbSite: improved prediction of human ubiquitination sites by exploiting amino acid pattern and properties.
Chen Z, Zhou Y, Song J, Zhang Z.
Biochim Biophys Acta. 2013 Aug;1834(8):1461-7. [
PMID: 23603789]
[10] Methylation of the retinoblastoma tumor suppressor by SMYD2.
Saddic LA, West LE, Aslanian A, Yates JR 3rd, Rubin SM, Gozani O, Sage J.
J Biol Chem. 2010 Nov 26;285(48):37733-40. [
PMID: 20870719]
[11] Acetylation control of the retinoblastoma tumour-suppressor protein.
Chan HM, Krstic-Demonacos M, Smith L, Demonacos C, La Thangue NB.
Nat Cell Biol. 2001 Jul;3(7):667-74. [
PMID: 11433299]
[12] Acetylation regulates the differentiation-specific functions of the retinoblastoma protein.
Nguyen DX, Baglia LA, Huang SM, Baker CM, McCance DJ.
EMBO J. 2004 Apr 7;23(7):1609-18. [
PMID: 15044952]
[13] p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation.
Leduc C, Claverie P, Eymin B, Col E, Khochbin S, Brambilla E, Gazzeri S.
Oncogene. 2006 Jul 13;25(30):4147-54. [
PMID: 16501607]
[14] Lysine methylation regulates the pRb tumour suppressor protein.
Munro S, Khaire N, Inche A, Carr S, La Thangue NB.
Oncogene. 2010 Apr 22;29(16):2357-67. [
PMID: 20140018]
[15] Regulation of cellular metabolism by protein lysine acetylation.
Zhao S, Xu W, Jiang W, Yu W, Lin Y, Zhang T, Yao J, Zhou L, Zeng Y, Li H, Li Y, Shi J, An W, Hancock SM, He F, Qin L, Chin J, Yang P, Chen X, Lei Q, Xiong Y, Guan KL.
Science. 2010 Feb 19;327(5968):1000-4. [
PMID: 20167786]